Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. DEF 14A Proxy Proxy Statement
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. 8-K Event Bylaws or fiscal year change
  4. 8-K Event Material agreement · Regulation FD disclosure
  5. 4 Grant or award Director acquired 4,259 shares (grant or award)
  6. 4 Grant or award Director acquired 5,370 shares (grant or award)
  7. 144 Insider Sale of Securities
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. 4 Shares withheld for taxes Chief Business Officer gave up 9,004 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,446 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief People Officer gave up 9,004 shares (to pay taxes)
  14. 4 Shares withheld for taxes President & CEO gave up 48,211 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 16,579 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 17,244 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Accounting Officer gave up 3,268 shares (to pay taxes)
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 3 of 28 · 548 filings